1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
3.8. Products in Pipeline
4. TECHNOLOGICAL OUTLOOK
5. HUNTINGTON’S DISEASE TREATMENT MARKET BY TYPE
5.1. Introduction
5.2. Medication
5.2.1. Tetrabenazine
5.2.2. Deutetrabenazine
5.2.3. Others
5.3. Therapy
5.3.1. Physical Therapy
5.3.2. Speech Therapy
5.3.3. Disease Modifying Therapy
6. HUNTINGTON’S DISEASE TREATMENT MARKET BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Injectable
6.3. Oral
7. HUNTINGTON’S DISEASE TREATMENT MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Specialty Clinics
7.4. Others
8. HUNTINGTON’S DISEASE TREATMENT MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Teva Pharmaceutical Industries Ltd.
10.2. H. Lundbeck A/S
10.3. Bausch Health Companies Inc
10.4. Neurocrine Biosciences, Inc.
10.5. Prilenia Therapeutics
10.6. Novartis AG
10.7. Lupin Limited
10.8. Hikma Pharmaceuticals PLC
10.9. Dr. Reddy's Laboratories Ltd
10.10. Atalanta Therapeutics
10.11. F. Hoffmann-La Roche AG
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES